glp 1 and schizophrenia Glucagon-like peptide-1 receptor agonists risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study GLP-1s may improve some mental

It started with Look how much weight I lost! and now, increasingly, its Why do I look so tired? or Why is my skin sagging? or the big one: Where did my muscle go? You arent looking for a magic pill that leaves you frail

It plays a role in nerve function, muscle contraction, and energy production

GLP-1 is rapidly degraded by DPP-4 under normal circumstances

The analytical challenge: Why peptides are harder to analyze Despite their therapeutic promise, peptide-based drugs present unique analytical and manufacturing challenges that differentiate them from traditional small-molecule pharmaceuticals

For more information: Ezekiel Emanuel, MD, PhD, and Tricia Rodriguez, PhD, MPH, can be reached at [email protected].